Wijziging van de Wet geneesmiddelenprijzen in verband met een aanpassing van de referentielanden

This amendment proposes changes to the Dutch Medicines Prices Act. The goal is to adjust the reference countries used for setting medicine prices, potentially impacting affordability and availability. This procedure affects pharmaceutical companies, healthcare providers, and patients in the Netherlands. It aims to ensure fair pricing by updating the comparison countries for drug cost evaluation.